Circassia Pharmaceuticals said last week that it inked a deal for the exclusive commercialization rights to AIT Therapeutics’ nitric oxide device, AirNOvent, in the U.S. and China.
Using an electric voltage, the portable AirNOvent system produces nitric oxide from the nitrogen and oxygen in the air.
Get the full story at our sister site, Drug Delivery Business News.
The post Circassia inks exclusive ventilator commercialization deal with AIT Therapeutics appeared first on MassDevice.